Annex Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Sell
248,253
-2,357
-0.9% -$242K 0.41% 61
2026
Q1
$27.4M Buy
250,610
+6,901
+3% +$658K 0.51% 57
2025
Q4
$19.8M Buy
243,709
+13,692
+6% +$1.18M 0.38% 65
2025
Q3
$20.1M Buy
230,017
+10,350
+5% +$924K 0.43% 59
2025
Q2
$18.2M Buy
219,667
+185,085
+535% +$15.5M 0.44% 54
2025
Q1
$2.9M Buy
34,582
+2,905
+9% +$270K 0.08% 104
2024
Q4
$2.92M Buy
31,677
+1,769
+6% +$170K 0.09% 104
2024
Q3
$2.78M Buy
29,908
+1,318
+5% +$114K 0.09% 101
2024
Q2
$2.35M Buy
28,590
+2,441
+9% +$179K 0.08% 102
2024
Q1
$1.74M Buy
26,149
+1,315
+5% +$81.1K 0.06% 107
2023
Q4
$1.41M Buy
24,834
+12,745
+105% +$668K 0.06% 108
2023
Q3
$659K Buy
12,089
+2,233
+23% +$132K 0.04% 127
2023
Q2
$663K Buy
9,856
+1,255
+15% +$76.6K 0.04% 127
2023
Q1
$443K Buy
8,601
+805
+10% +$39.1K 0.02% 146
2022
Q4
$359K Buy
7,796
+2,267
+41% +$106K 0.02% 173
2022
Q3
$280K Buy
5,529
+251
+5% +$12.5K 0.02% 184
2022
Q2
$240K Buy
+5,278
New +$236K 0.02% 220

Other funds holding LMAT